https://cn.bioecon.ru/technologies/gene-therapy/Recent content in Gene-Therapy on 生物经济Hugozh-CNSun, 28 Jun 2026 20:00:11 +0700https://cn.bioecon.ru/technology/personalized-regenerative-medicine/Fri, 19 Jun 2026 00:00:00 +0000https://cn.bioecon.ru/technology/personalized-regenerative-medicine/针对罕见单基因病和肿瘤疾病的基因与细胞治疗平台：AAV载体、慢病毒HSC编辑、体外CRISPR（Casgevy）和体内CRISPR（LNP递送）已获FDA和EMA批准，可实现持久的单次给药治疗。